Results

RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/SHA-384/DE6B22DE034F9420772D62B0F86EB6948D2DEF5203468E446CF53ACC27489FC09B70112514227BC8DE6ECBB991C6C9F7http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/DE6B22DE034F9420772D62B0F86EB6948D2DEF5203468E446CF53ACC27489FC09B70112514227BC8DE6ECBB991C6C9F7http://www.w3.org/2000/01/rdf-schema#comment"our results first identified that the proper increase of PD-1/STAT1 may contribute to hematopoietic improvement and prolonged survival in lower risk MDS. Our study proposed that the PD-1-related strategy to treat MDS should be different for lower risk patients than it is for those with highly progressive characteristics."xsd:string
http://purl.uniprot.org/uniprot/#_25F412D524A8F53C614A73B0A1F969FA68D6ADD8B1A261EEF5EB474157563DCC3A5F5C9E6CF5A35C559A0351D1EA5663http://www.w3.org/1999/02/22-rdf-syntax-ns#subjecthttp://purl.uniprot.org/SHA-384/DE6B22DE034F9420772D62B0F86EB6948D2DEF5203468E446CF53ACC27489FC09B70112514227BC8DE6ECBB991C6C9F7
http://purl.uniprot.org/uniprot/A0A0M3M0G7http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/DE6B22DE034F9420772D62B0F86EB6948D2DEF5203468E446CF53ACC27489FC09B70112514227BC8DE6ECBB991C6C9F7
http://purl.uniprot.org/uniprot/#_A0A0M3M0G7-mappedCitation-27686004http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/DE6B22DE034F9420772D62B0F86EB6948D2DEF5203468E446CF53ACC27489FC09B70112514227BC8DE6ECBB991C6C9F7